Product image
InVivoPlus polyclonal Armenian hamster IgG
BP0091
Product group Antibodies
Overview
- SupplierBio X Cell
- Product NameInVivoPlus polyclonal Armenian hamster IgG
- Delivery Days Customer7
- CertificationResearch Use Only
- ClonalityPolyclonal
- Clone IDpolyclonal Armenian hamster IgG
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostHamster
- IsotypeIgG
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade. Ariyan CE et al., 2018 Feb, Cancer Immunol ResRead more
- PU.1 Expression in T Follicular Helper Cells Limits CD40L-Dependent Germinal Center B Cell Development. Awe O et al., 2015 Oct 15, J ImmunolRead more
- Cutting Edge: PD-1 Regulates Imiquimod-Induced Psoriasiform Dermatitis through Inhibition of IL-17A Expression by Innate gammadelta-Low T Cells. Imai Y et al., 2015 Jul 15, J ImmunolRead more
- ADAP and SKAP55 deficiency suppresses PD-1 expression in CD8+ cytotoxic T lymphocytes for enhanced anti-tumor immunotherapy. Li C et al., 2015 Jun, EMBO Mol MedRead more
- Intratumoral administration of mRNA encoding a fusokine consisting of IFN-beta and the ectodomain of the TGF-beta receptor II potentiates antitumor immunity. Van der Jeught K et al., 2014 Oct 30, OncotargetRead more
- Role of disease-associated tolerance in infectious superspreaders. Gopinath S et al., 2014 Nov 4, Proc Natl Acad Sci U S ARead more
- Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice. Khmaladze Ia et al., 2014 Sep 2, Proc Natl Acad Sci U S ARead more
- Epitope-specific regulation of memory programming by differential duration of antigen presentation to influenza-specific CD8(+) T cells. Ballesteros-Tato A et al., 2014 Jul 17, ImmunityRead more
- Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Oezdemir BC et al., 2014 Jun 16, Cancer CellRead more
- Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells. Church SE et al., 2014 Jan, Eur J ImmunolRead more